HUP0103621A3 - Fentanyl composition for the treatment of acute pain - Google Patents
Fentanyl composition for the treatment of acute painInfo
- Publication number
- HUP0103621A3 HUP0103621A3 HU0103621A HUP0103621A HUP0103621A3 HU P0103621 A3 HUP0103621 A3 HU P0103621A3 HU 0103621 A HU0103621 A HU 0103621A HU P0103621 A HUP0103621 A HU P0103621A HU P0103621 A3 HUP0103621 A3 HU P0103621A3
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- acute pain
- fentanyl composition
- fentanyl
- composition
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title 1
- 208000005298 acute pain Diseases 0.000 title 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 title 1
- 229960002428 fentanyl Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803239A SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Composition for the treatment of acute pain |
PCT/SE1999/001688 WO2000016751A1 (en) | 1998-09-24 | 1999-09-24 | Fentanyl composition for the treatment of acute pain |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0103621A2 HUP0103621A2 (hu) | 2002-02-28 |
HUP0103621A3 true HUP0103621A3 (en) | 2005-05-30 |
HU228992B1 HU228992B1 (en) | 2013-07-29 |
Family
ID=20412701
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1300339A HU230688B1 (hu) | 1998-09-24 | 1999-09-24 | Fentanil készítmény akut fájdalom kezelésére |
HU0103621A HU228992B1 (en) | 1998-09-24 | 1999-09-24 | Sublingual fentanyl composition for the treatment of acute pain |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1300339A HU230688B1 (hu) | 1998-09-24 | 1999-09-24 | Fentanil készítmény akut fájdalom kezelésére |
Country Status (26)
Country | Link |
---|---|
US (1) | US6759059B1 (hu) |
EP (1) | EP1115384B1 (hu) |
JP (2) | JP2002526440A (hu) |
KR (1) | KR100760531B1 (hu) |
CN (1) | CN1170524C (hu) |
AT (1) | ATE247950T1 (hu) |
AU (1) | AU764473B2 (hu) |
BG (1) | BG65363B1 (hu) |
BR (1) | BR9913948B1 (hu) |
CA (1) | CA2345064C (hu) |
CZ (1) | CZ301562B6 (hu) |
DE (1) | DE69910803T2 (hu) |
DK (1) | DK1115384T3 (hu) |
EE (1) | EE200100176A (hu) |
ES (1) | ES2207295T3 (hu) |
HU (2) | HU230688B1 (hu) |
IL (2) | IL142126A0 (hu) |
NO (1) | NO332228B1 (hu) |
NZ (1) | NZ510646A (hu) |
PL (1) | PL197078B1 (hu) |
PT (1) | PT1115384E (hu) |
RU (1) | RU2232580C2 (hu) |
SE (1) | SE9803239D0 (hu) |
SK (1) | SK283503B6 (hu) |
TR (1) | TR200100812T2 (hu) |
WO (1) | WO2000016751A1 (hu) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
KR101476574B1 (ko) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
IT1318618B1 (it) * | 2000-07-10 | 2003-08-27 | A C R Applied Coating Res S A | Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi. |
DE20122843U1 (de) | 2000-07-31 | 2008-06-26 | Nycomed Danmark Aps | Fentanyl Zusammensetzung zur nasalen Anwendung |
BR0115382A (pt) | 2000-10-30 | 2003-09-16 | Euro Celtique Sa | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica |
WO2003002071A2 (en) * | 2001-06-29 | 2003-01-09 | Lewandowski Leon J | Individualized addiction cessation therapy |
FR2827517B1 (fr) * | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
ES2284783T3 (es) * | 2001-11-16 | 2007-11-16 | Randox Laboratories Ltd. | Metodo y estuche para detectar, o determinar la cantidad de,metabolitos de fentanilo y metabolitos de analogos de fentanilo. |
GB0217056D0 (en) * | 2002-07-23 | 2002-08-28 | Ass Octel | Use |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
AU2004208644B2 (en) * | 2003-01-31 | 2009-07-23 | Orexo Ab | A rapid-acting pharmaceutical composition |
KR20050115276A (ko) * | 2003-03-11 | 2005-12-07 | 아라키스 리미티드 | 신규한 조성물 |
JP5137286B2 (ja) | 2003-06-10 | 2013-02-06 | 帝國製薬株式会社 | フェンタニル含有口腔粘膜貼付剤 |
GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
CA2548915C (en) | 2003-12-31 | 2012-10-16 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
JP5244318B2 (ja) | 2003-12-31 | 2013-07-24 | シーマ・ラブス、インコーポレイテッド | 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法 |
WO2005065317A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Effervescent oral fentanyl dosage form |
JP5179757B2 (ja) * | 2004-02-17 | 2013-04-10 | トランセプト ファーマシューティカルズ, インコーポレイティド | 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法 |
GB0423800D0 (en) | 2004-10-27 | 2004-12-01 | Orexo Ab | New pharmaceutical formulations |
FR2883179B1 (fr) * | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
MX2007011977A (es) * | 2005-03-28 | 2007-12-07 | Orexo Ab | Composiciones farmaceuticas novedosas utiles en el tratamiento del dolor. |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
KR20080031208A (ko) * | 2005-05-25 | 2008-04-08 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 야반 불면증을 치료하기 위한 고체 조성물 및 방법 |
EP1968539A2 (en) * | 2005-12-13 | 2008-09-17 | Biodelivery Sciences International, Inc. | Abuse resistant transmucosal drug delivery device |
CN106727271B (zh) * | 2006-01-06 | 2020-02-14 | 阿塞尔Rx制药有限公司 | 小体积口腔经粘膜剂型 |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
AU2007208229B2 (en) | 2006-01-25 | 2009-11-05 | Insys Therapeutics Inc. | Sublingual fentanyl spray |
EP1837020A1 (en) | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
US20070260491A1 (en) * | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20070286900A1 (en) * | 2006-06-09 | 2007-12-13 | Catherine Herry | Low dose tablets of opioid analgesics and preparation process |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
RU2504377C2 (ru) | 2006-07-21 | 2014-01-20 | БайоДеливери Сайенсиз Интэнэшнл, Инк. | Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
US20080090874A1 (en) * | 2006-09-20 | 2008-04-17 | Messina John C Jr | Treatment of breakthrough pain in patients suffering from chronic low back pain |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
SI2101740T1 (sl) * | 2006-12-04 | 2014-03-31 | Orexo Ab | Nov nezlorabljiv farmacevtski sestavek, obsegajoč opiode |
JP2010518086A (ja) | 2007-02-09 | 2010-05-27 | デュレクト コーポレーション | スフェンタニルおよびナロキソンを含む経口腔投与製剤 |
US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
US20080287494A1 (en) * | 2007-04-24 | 2008-11-20 | Cephalon, Inc. | Transmucosal treatment methods in patients with mucositis |
JP2010529073A (ja) * | 2007-06-06 | 2010-08-26 | ビーエーエスエフ ソシエタス・ヨーロピア | チュアブル錠及びトローチ剤製造のための医薬製剤 |
AU2008282743B2 (en) | 2007-08-02 | 2012-11-29 | Insys Therapeutics Inc. | Sublingual fentanyl spray |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
EP2295046B1 (de) * | 2009-09-14 | 2012-12-19 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon |
WO2011041414A1 (en) | 2009-09-30 | 2011-04-07 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
NZ599594A (en) | 2009-10-30 | 2014-06-27 | Ix Biopharma Ltd | Fast dissolving solid dosage form |
US8927025B2 (en) | 2010-05-11 | 2015-01-06 | Cima Labs Inc. | Alcohol-resistant metoprolol-containing extended-release oral dosage forms |
US20120183580A1 (en) * | 2011-01-13 | 2012-07-19 | Theralpha | Analgesic Composition for Transbuccal Administration |
SG10201610097WA (en) | 2011-08-18 | 2017-01-27 | Biodelivery Sciences Int Inc | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
LT2915525T (lt) | 2011-09-19 | 2021-09-27 | Orexo Ab | Poliežuvinės, piktnaudžiavimui atsparios tabletės, apimančios buprenorfiną ir naloksoną |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
DE102012006396A1 (de) | 2012-03-29 | 2013-10-02 | Willy Rüsch GmbH | Tracheostomietubus |
PE20142444A1 (es) | 2012-05-02 | 2015-01-09 | Orexo Ab | Nueva composicion de alfentanilo para el tratamiento del dolor agudo |
CN107595793B (zh) | 2012-11-30 | 2020-11-13 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
WO2015065547A1 (en) | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
US20160331693A1 (en) * | 2014-02-07 | 2016-11-17 | Scilabs Pharmaceuticals | All natural, non-toxic sublingual drug delievery systems |
WO2016086095A1 (en) | 2014-11-25 | 2016-06-02 | Biodelivery Sciences International, Inc. | Patches, methods for forming and testing pharmaceutical agent delivery patches |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US11324707B2 (en) | 2019-05-07 | 2022-05-10 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8332556D0 (en) * | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
SE8800080L (sv) * | 1988-01-13 | 1989-07-14 | Kabivitrum Ab | Laekemedelskomposition |
JP3836566B2 (ja) * | 1996-05-13 | 2006-10-25 | 久光製薬株式会社 | フェンタニル含有経皮投与テープ製剤 |
JP3943724B2 (ja) * | 1998-07-31 | 2007-07-11 | 東光薬品工業株式会社 | フェンタニル含有経皮投与マトリックス型貼付剤 |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
-
1998
- 1998-09-24 SE SE9803239A patent/SE9803239D0/xx unknown
-
1999
- 1999-09-24 ES ES99952868T patent/ES2207295T3/es not_active Expired - Lifetime
- 1999-09-24 SK SK401-2001A patent/SK283503B6/sk not_active IP Right Cessation
- 1999-09-24 DE DE69910803T patent/DE69910803T2/de not_active Expired - Lifetime
- 1999-09-24 AT AT99952868T patent/ATE247950T1/de active
- 1999-09-24 EE EEP200100176A patent/EE200100176A/xx unknown
- 1999-09-24 BR BRPI9913948-0A patent/BR9913948B1/pt not_active IP Right Cessation
- 1999-09-24 TR TR2001/00812T patent/TR200100812T2/xx unknown
- 1999-09-24 NZ NZ510646A patent/NZ510646A/en not_active IP Right Cessation
- 1999-09-24 CA CA002345064A patent/CA2345064C/en not_active Expired - Lifetime
- 1999-09-24 CN CNB998136220A patent/CN1170524C/zh not_active Expired - Fee Related
- 1999-09-24 DK DK99952868T patent/DK1115384T3/da active
- 1999-09-24 PT PT99952868T patent/PT1115384E/pt unknown
- 1999-09-24 KR KR1020017003714A patent/KR100760531B1/ko active IP Right Grant
- 1999-09-24 CZ CZ20011030A patent/CZ301562B6/cs not_active IP Right Cessation
- 1999-09-24 JP JP2000573712A patent/JP2002526440A/ja not_active Withdrawn
- 1999-09-24 EP EP99952868A patent/EP1115384B1/en not_active Expired - Lifetime
- 1999-09-24 US US09/787,887 patent/US6759059B1/en not_active Expired - Lifetime
- 1999-09-24 PL PL347467A patent/PL197078B1/pl unknown
- 1999-09-24 WO PCT/SE1999/001688 patent/WO2000016751A1/en active IP Right Grant
- 1999-09-24 AU AU64928/99A patent/AU764473B2/en active Active
- 1999-09-24 HU HU1300339A patent/HU230688B1/hu unknown
- 1999-09-24 IL IL14212699A patent/IL142126A0/xx active IP Right Grant
- 1999-09-24 HU HU0103621A patent/HU228992B1/hu unknown
- 1999-09-24 RU RU2001111026/15A patent/RU2232580C2/ru active
-
2001
- 2001-03-20 IL IL142126A patent/IL142126A/en not_active IP Right Cessation
- 2001-03-23 BG BG105380A patent/BG65363B1/bg unknown
- 2001-03-23 NO NO20011502A patent/NO332228B1/no not_active IP Right Cessation
-
2004
- 2004-06-04 JP JP2004167572A patent/JP4478512B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103621A3 (en) | Fentanyl composition for the treatment of acute pain | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
HUP0100765A3 (en) | Composition for the treatment of halitosis | |
HUP0101685A3 (en) | Hair treatment composition | |
HUP0202853A3 (en) | Use of retigabin for treating neuropathic pain | |
GB9824436D0 (en) | Methods of treatment | |
IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
GB9816234D0 (en) | Compounds for use in the treatment of inflammation | |
IL133760A0 (en) | Composition for the treatment of dandruff | |
HUP0101947A3 (en) | Combination for the treatment of tumors | |
EP1007041A4 (en) | COMPOSITION FOR TREATING PAIN | |
AU2420101A (en) | Method and composition for the treatment of pain | |
EP1096927A4 (en) | STRESS TREATMENT COMPOSITION | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
GB9904252D0 (en) | Composition for the treatment of pain | |
IL150202A0 (en) | Method and composition for the treatment of pain | |
GB9810856D0 (en) | Hair treatment composition | |
IL150208A0 (en) | Compound and method for the treatment of pain | |
GB2343629B (en) | Treatment of cellulite | |
GB0020261D0 (en) | Therapeutic treatment | |
AU2420201A (en) | Compounds and methods for the treatment of pain | |
GB9918000D0 (en) | Compositions for the treatment of pain | |
HUP0103568A3 (en) | Treatment of depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: OREXO AB, SE Free format text: FORMER OWNER(S): DIABACT AB, SE |